Breast Cancer

Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant

By Chen Nahshon, Leen Fahoum, Dana Hadar, Yakir Segev

Cohort study of 1,677 peoplePopulations

Dose-response, declared no competing interests

The paper

Chen Nahshon, Leen Fahoum, Dana Hadar, Yakir Segev

Technion – Israel Institute of Technology

Breast Cancer, 18 Aug 2026

doi.org/10.1007/s12282-026-01890-z PubMed 42611417

Research Square7 Oct 2026
Inherited gene variants linked to breast cancer risk in UAE
Medicine and Science in Sports and Exercise7 Oct 2026
Fitness linked to less excess breast cancer risk after menopause
medRxiv6 Oct 2026
Hormone therapy linked to lower breast cancer mortality
medRxiv4 Oct 2026
Estrogen-responsive variants interact with reproductive risk factors